401 results found (maximum 10,000)
Click on the company for more information on the subsidy award. Click on the parent name to reach the summary page for that parent company.
Download results as 
or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
| Company | Parent | Location | Subsidy Source | Year |
Subsidy Value |
Loan/Bailout Value | Type of Subsidy |
|---|---|---|---|---|---|---|---|
| ACAMBIS INC | Sanofi | United States | federal | 2004 | $67,000,000 | federal grant | |
| Novozymes Blair, Inc. | Novo Holdings A/S | United States | federal | 2010 | $28,401,000 | federal allocated tax credit | |
| AMYRIS, INC. | Amyris | United States | federal | 2010 | $24,341,409 | federal grant | |
| XOMA (US) LLC | Xoma Corp. | United States | federal | 2005 | $15,000,000 | federal grant | |
| NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, | Novartis | United States | federal | 2017 | $12,060,156 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2000 | $11,094,599 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2004 | $10,427,728 | federal grant | |
| CELGENE CORPORATION | Bristol-Myers Squibb | United States | federal | 2010 | $10,061,240 | federal grant | |
| SHIRE BIOLOGICS INC | Takeda Pharmaceutical | United States | federal | 2004 | $9,500,092 | federal grant | |
| ACAMBIS INC | Sanofi | United States | federal | 2005 | $9,284,386 | federal grant | |
| ACAMBIS INC | Sanofi | United States | federal | 2003 | $9,241,818 | federal grant | |
| CHIMERIX INC | Chimerix | United States | federal | 2005 | $8,477,202 | federal grant | |
| CHIMERIX INC | Chimerix | United States | federal | 2004 | $7,492,027 | federal grant | |
| CELGENE CORPORATION | Bristol-Myers Squibb | United States | federal | 2012 | $7,489,743 | federal grant | |
| WYETH PHARMACEUTICALS INC | Pfizer | United States | federal | 2003 | $7,271,925 | federal grant | |
| AMYRIS, INC. | Amyris | United States | federal | 2016 | $7,000,000 | federal grant | |
| AMYRIS, INC. | Amyris | United States | federal | 2018 | $7,000,000 | federal grant | |
| AMYRIS, INC. | Amyris | United States | federal | 2019 | $7,000,000 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2005 | $6,884,362 | federal grant | |
| AMYRIS, INC. | Amyris | United States | federal | 2018 | $6,825,720 | federal grant | |
| WYETH PHARMACEUTICALS INC | Pfizer | United States | federal | 2005 | $6,364,931 | federal grant | |
| WYETH | Pfizer | United States | federal | 2005 | $5,636,276 | federal grant | |
| TAKEDA VACCINES, INC. | Takeda Pharmaceutical | United States | federal | 2018 | $5,385,144 | federal grant | |
| WYETH PHARMACEUTICALS INC | Pfizer | United States | federal | 2005 | $4,934,072 | federal grant | |
| AVENTIS PASTEUR, INC | Sanofi | United States | federal | 2004 | $4,923,670 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2002 | $4,920,585 | federal grant | |
| MEDIMMUNE, LLC | AstraZeneca | United States | federal | 2018 | $4,893,180 | federal grant | |
| AMYRIS, INC. | Amyris | United States | federal | 2019 | $4,879,153 | federal grant | |
| MEDIMMUNE, LLC | AstraZeneca | United States | federal | 2017 | $4,864,964 | federal grant | |
| NOVOZYMES, INC | Novo Holdings A/S | United States | federal | 2008 | $4,694,082 | federal grant | |
| NOVOZYMES, INC | Novo Holdings A/S | United States | federal | 2008 | $4,694,082 | federal grant | |
| REGENERON PHARMACEUTICALS INC | Regeneron Pharmaceuticals | United States | federal | 2007 | $4,614,400 | federal grant | |
| NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, | Novartis | United States | federal | 2014 | $4,327,868 | federal grant | |
| ETHICON, INC | Johnson & Johnson | United States | federal | 2009 | $4,260,809 | federal grant | |
| GlaxoSmithKline | GlaxoSmithKline | United States | federal | 2012 | $4,011,709 | federal grant | |
| NOVARTIS VACCINES DIAGNOSTICS, | Novartis | United States | federal | 2012 | $3,864,927 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2002 | $3,840,693 | federal grant | |
| PFIZER INC. | Pfizer | United States | federal | 2014 | $3,823,709 | federal grant | |
| AMERICAN HOME PRODUCTS CORPORATION | Pfizer | United States | federal | 2000 | $3,773,578 | federal grant | |
| CELGENE CORPORATION | Bristol-Myers Squibb | United States | federal | 2011 | $3,687,247 | federal grant | |
| AMYRIS BIOTECHNOLOGIES, INC | Amyris | United States | federal | 2012 | $3,595,518 | federal grant | |
| AMERICAN HOME PRODUCTS CORPORATION | Pfizer | United States | federal | 2004 | $3,582,393 | federal grant | |
| NOVOZYMES, INC | Novo Holdings A/S | United States | federal | 2009 | $3,289,888 | federal grant | |
| AMERICAN HOME PRODUCTS CORPORATION | Pfizer | United States | federal | 2001 | $3,247,250 | federal grant | |
| CELGENE CORPORATION | Bristol-Myers Squibb | United States | federal | 2009 | $3,170,533 | federal grant | |
| AVENTIS PASTEUR, INC | Sanofi | United States | federal | 2003 | $3,121,883 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2003 | $2,984,358 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2003 | $2,984,358 | federal grant | |
| WYETH PHARMACEUTICALS INC | Pfizer | United States | federal | 2002 | $2,968,632 | federal grant | |
| PFIZER INC. | Pfizer | United States | federal | 2014 | $2,784,665 | federal grant | |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | United States | federal | 2012 | $2,713,491 | federal grant | |
| NOVARTIS VACCINES AND DIAGNOSTICS, INC | Novartis | United States | federal | 2014 | $2,713,057 | federal grant | |
| NOVAVAX, INC | Novavax Inc. | United States | federal | 2003 | $2,695,203 | federal grant | |
| GENOCEA BIOSCIENCES INC | Genocea Biosciences | United States | federal | 2009 | $2,685,993 | federal grant | |
| ACORDA THERAPEUTICS, INC | Acorda Therapeutics | United States | federal | 2013 | $2,675,008 | federal grant | |
| NOVOZYMES, INC. | Novo Holdings A/S | United States | federal | 2013 | $2,500,000 | federal grant | |
| NOVOZYMES, INC. | Novo Holdings A/S | United States | federal | 2018 | $2,500,000 | federal grant | |
| NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, | Novartis | United States | federal | 2015 | $2,473,302 | federal grant | |
| SANOFI PASTEUR VAXDESIGN CORPORATION | Sanofi | United States | federal | 2014 | $2,433,738 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2004 | $2,407,540 | federal grant | |
| MEDIMMUNE, LLC | AstraZeneca | United States | federal | 2018 | $2,383,754 | federal grant | |
| SANOFI US SERVICES INC. | Sanofi | United States | federal | 2018 | $2,382,409 | federal grant | |
| SANOFI US SERVICES INC. | Sanofi | United States | federal | 2021 | $2,382,402 | federal grant | |
| AVENTIS PASTEUR, INC | Sanofi | United States | federal | 2004 | $2,362,639 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2001 | $2,359,223 | federal grant | |
| STRATATECH CORPORATION | Mallinckrodt | United States | federal | 2016 | $2,357,660 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2003 | $2,306,242 | federal grant | |
| MORPHOTEK INC | Eisai | United States | federal | 2007 | $2,265,000 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2004 | $2,255,121 | federal grant | |
| PTC THERAPEUTICS, INC | PTC Therapeutics | United States | federal | 2006 | $2,219,415 | federal grant | |
| PROTEIN SCIENCES CORPORATION | Sanofi | United States | federal | 2003 | $2,213,730 | federal grant | |
| NOVOZYMES, INC | Novo Holdings A/S | United States | federal | 2010 | $2,156,352 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2004 | $2,040,362 | federal grant | |
| CHIMERIX INC | Chimerix | United States | federal | 2003 | $2,005,821 | federal grant | |
| EASEL BIOTECHNOLOGIES | Bristol-Myers Squibb | United States | federal | 2015 | $2,000,000 | federal grant | |
| EASEL BIOTECHNOLOGIES | Bristol-Myers Squibb | United States | federal | 2018 | $2,000,000 | federal grant | |
| FLEXION THERAPEUTICS, INC. | Pacira BioSciences | United States | federal | 2013 | $1,970,121 | federal grant | |
| SANOFI PASTEUR VAXDESIGN CORPORATION | Sanofi | United States | federal | 2015 | $1,923,532 | federal grant | |
| AMERICAN HOME PRODUCTS CORPORATION | Pfizer | United States | federal | 2002 | $1,894,602 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2002 | $1,894,091 | federal grant | |
| INSMED INCORPORATED | Insmed Inc. | United States | federal | 2019 | $1,839,040 | federal grant | |
| INSMED INCORPORATED | Insmed Inc. | United States | federal | 2020 | $1,839,040 | federal grant | |
| MORPHOTEK INC | Eisai | United States | federal | 2008 | $1,776,380 | federal grant | |
| NOVARTIS VACCINES AND DIAGNOSTICS, INC | Novartis | United States | federal | 2015 | $1,717,293 | federal grant | |
| SANOFI PASTEUR VAXDESIGN CORPORATION | Sanofi | United States | federal | 2018 | $1,627,483 | federal grant | |
| AMERICAN HOME PRODUCTS CORPORATION | Pfizer | United States | federal | 2003 | $1,616,058 | federal grant | |
| IMMUNOMEDICS, INC. | Gilead Sciences | United States | federal | 2013 | $1,615,021 | federal grant | |
| REGENERON PHARMACEUTICALS INC | Regeneron Pharmaceuticals | United States | federal | 2010 | $1,595,238 | federal grant | |
| IBIS BIOSCIENCES INC | Abbott Laboratories | United States | federal | 2009 | $1,591,169 | federal grant | |
| ANIMAS CORPORATION | Johnson & Johnson | United States | federal | 2001 | $1,589,000 | federal grant | |
| NOVOZYMES NORTH AMERICA, INC. | Novo Holdings A/S | United States | federal | 2017 | $1,568,670 | federal grant | |
| NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, | Novartis | United States | federal | 2018 | $1,546,698 | federal grant | |
| OPTIMER PHARMACEUTICALS INC | Merck | United States | federal | 2005 | $1,521,978 | federal grant | |
| REGENERON PHARMACEUTICALS INC | Regeneron Pharmaceuticals | United States | federal | 2006 | $1,521,300 | federal grant | |
| SANOFI PASTEUR VAXDESIGN CORPORATION | Sanofi | United States | federal | 2017 | $1,500,013 | federal grant | |
| PROTEIN SCIENCES CORPORATION | Sanofi | United States | federal | 2001 | $1,478,925 | federal grant | |
| EMBREX, INC. | Pfizer | United States | federal | 2005 | $1,403,707 | federal grant | |
| CELGENE CORPORATION | Bristol-Myers Squibb | United States | federal | 2011 | $1,400,000 | federal grant | |
| CHEMOCENTRYX, INC. | ChemoCentryx | United States | federal | 2000 | $1,372,600 | federal grant | |
| ALEXION ANTIBODY TECHNOLOGIES | AstraZeneca | United States | federal | 2005 | $1,356,000 | federal grant | |
| AMYRIS, INC. | Amyris | United States | federal | 2014 | $1,353,490 | federal grant |
Download results as or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)